Last reviewed · How we verify
Squamous cell carcinoma of esophagus
Approved treatments
- Pembrolizuma · Memorial Sloan Kettering Cancer Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Squamous cell carcinoma of esophagus patent landscape — cliff calendar, originator estates, attackable patents
- Squamous cell carcinoma of esophagus treatment landscape brief
- Squamous cell carcinoma of esophagus treatment updates RSS
Frequently asked questions about Squamous cell carcinoma of esophagus
What drugs treat Squamous cell carcinoma of esophagus?
Tracked treatments include Pembrolizuma.
What is the treatment for Squamous cell carcinoma of esophagus?
Standard treatment for Squamous cell carcinoma of esophagus includes Pembrolizuma. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Squamous cell carcinoma of esophagus patent cliff · Squamous cell carcinoma of esophagus CI report
- Treatment: Pembrolizuma · Memorial Sloan Kettering Cancer Center
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing